UR9 Intrinsic Valuation and Fundamental Analysis - Clinuvel Pharmaceuticals Ltd

	Clinuvel Pharmaceuticals Ltd F:UR9	AU
S	Sony Group Corp F:SON1	JP
B	Brady Corp F:BRV	US
O	Oversea-Chinese Banking Corporation Ltd F:OCBA	SG
C	Canada Nickel Company Inc F:4E0	CA
I	Intesa Sanpaolo SpA XMUN:IES	IT
W	Westpac Banking Corp F:WBC	AU
S	Sovereign Metals Ltd F:SVM	AU
D	DEME Group NV F:MT0	BE
O	Oversea-Chinese Banking Corporation Ltd XMUN:OCBA	SG
H	Hacksaw AB STO:HACK	SE

Intrinsic Value

UR9 price has not been updated for more than 2 years. This may indicate that the stock has been delisted.

The intrinsic value for Clinuvel Pharmaceuticals Ltd (UR9) under the Base Case is hidden EUR. Compared with the current market price of 5.3 EUR, the stock appears hidden .

Intrinsic value calculated as an equal blend of DCF

Locked

and Multiples

Locked

Other reference points

Wall St target

€12.72

Do our valuations actually work? See backtest results .

UR9 Intrinsic Value

Unlock

UR9 looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if UR9 is one of them.

See where today’s valuation sits in UR9’s own history and what typically happened over the next 12 months after similar periods.

Show Historical Valuation

What is Valuation History?

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Current Price €5.3

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Clinuvel Pharmaceuticals Ltd.

Explain Valuation